Literature DB >> 1414496

Is heritability a risk factor for postmenopausal osteoporosis?

M A Hansen1, C Hassager, S B Jensen, C Christiansen.   

Abstract

We investigated heritability as a risk factor for the development of osteoporosis in two randomly selected populations of postmenopausal women and their premenopausal daughters. We determined the familial resemblance in bone mass at three sites; the distal forearm, lumbar spine, and proximal femur, premenopausally and with increasing maternal postmenopausal age. We also examined the bone mass of daughters in relation to mothers with and without osteoporotic fractures. Peak bone mass among premenopausal siblings was significantly correlated at all sites (r = 0.30-0.42, p less than 0.001). The same levels of resemblance were found between early postmenopausal mothers and premenopausal daughters. There was no significant difference in bone mass at any skeletal site between daughters of women with either peripheral or spinal fractures and daughters of women without fractures. We also examined familial resemblance with four biochemical markers of bone turnover (fasting urinary calcium and hydroxyproline, both corrected for creatinine, serum alkaline phosphatase, and plasma bone Gla protein). A generally significant resemblance were seen in premenopausal siblings (r = 0.25-0.39, hydroxyproline NS), but not between premenopausal daughters and postmenopausal mothers. We conclude that peak bone mass is hereditary in the distal forearm, lumbar spine, and proximal femur, but the mother-daughter resemblance explains only about 16% of the variability in daughters' bone mass. Furthermore, daughters of women with a moderate state of osteoporotic fractures are not substantially at an increased risk of having a low peak bone mass compared to the daughters of women without fractures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414496     DOI: 10.1002/jbmr.5650070906

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Familial resemblance of bone mineral density between females 18 years and older and their mothers.

Authors:  D Picard; A Imbach; M Couturier; R Lepage; M Picard
Journal:  Can J Public Health       Date:  2001 Sep-Oct

2.  Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years.

Authors:  A Leino; J Järvisalo; O Impivaara; M Kaitsaari
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

3.  Genetics of osteoporosis.

Authors:  M L Brandi; M L Bianchi; J A Eisman; F Glorieux; S Adami; C E Fiore; R Nuti; S Ortolani
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

4.  Osteopenia in 37 members of seven families: analysis based on a model of dominant inheritance.

Authors:  L D Spotila; J Caminis; M Devoto; K Shimoya; L Sereda; J Ott; M P Whyte; A Tenenhouse; D J Prockop
Journal:  Mol Med       Date:  1996-05       Impact factor: 6.354

5.  A novel locus on the X chromosome regulates post-maturity bone density changes in mice.

Authors:  Dorota Szumska; Helen Benes; Ping Kang; Robert S Weinstein; Robert L Jilka; Stavros C Manolagas; Robert J Shmookler Reis
Journal:  Bone       Date:  2006-12-19       Impact factor: 4.398

6.  Family resemblance of bone turnover rate in mothers and daughters--the MODAM study.

Authors:  H Nagy; R Chapurlat; E Sornay-Rendu; S Boutroy; P Szulc
Journal:  Osteoporos Int       Date:  2014-12-19       Impact factor: 4.507

7.  Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.

Authors:  Francesca Giusti; Silva Ottanelli; Laura Masi; Antonietta Amedei; Maria Luisa Brandi; Alberto Falchetti
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

8.  Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women.

Authors:  M A Hansen
Journal:  Osteoporos Int       Date:  1994-05       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.